Literature DB >> 27858553

Cross-Sectional Evaluation of Periodontal Status and Microbiologic and Rheumatoid Parameters in a Large Cohort of Patients With Rheumatoid Arthritis.

Jan Schmickler1, Annegret Rupprecht1, Susann Patschan2, Daniel Patschan2, Gerhard A Müller2, Rainer Haak1, Rainer F Mausberg3, Gerhard Schmalz1, Tanja Kottmann4, Dirk Ziebolz1.   

Abstract

BACKGROUND: This study evaluates periodontal conditions and microbiologic findings and their influence on rheumatologic disease parameters in patients with rheumatoid arthritis (RA).
METHODS: One hundred and sixty-eight patients with RA were included. A healthy control group (HC, n = 168) was composed according to age, sex, and smoking habits. Rheumatologic data (duration of illness, Disease Activity Score 28, rheumatic factor [RF], anti-cyclic citrullinated peptide [aCCP], medications) were extracted from patients' records. Dental examination included: 1) dental findings (decayed, missing, and/or filled adult teeth [DMF-T] index); 2) gingival inflammation (papillary bleeding index [PBI]); and 3) periodontal status (probing depth [PD], attachment loss [AL]). Periodontal condition was classified as healthy/mild, moderate, or severe periodontitis. Subgingival biofilm was analyzed regarding 11 periodontopathogenic bacteria. Statistical analyses included: 1) Kolmogorov-Smirnov test; 2) Mann-Whitney U test; 3) Pearson χ2 test; 4) Kruskal-Wallis test; and 5) regression analysis; level of significance α = 5%.
RESULTS: Mean DMF-T was significantly higher in patients with RA (19.3 ± 4.8) than in HC group (16.9 ± 5.8), especially owing to number of missing teeth (RA = 6.0 ± 5.4, HC = 3.1 ± 3.3; P <0.01). Patients with RA had a significantly higher proportion of increased PD (P <0.01) and AL compared with HC group (P <0.01). Moderate to severe periodontitis was noted in 98% of patients with RA and 82% of the HC group (P <0.01). RF-positive patients with RA suffered from worse periodontal conditions than RF-negative patients (P = 0.01). Age, PBI, and presence of Treponema denticola (P <0.03) are related to periodontal condition in patients with RA. Although not statistically significant, Porphyromonas gingivalis and Fusobacterium nucleatum occur in higher concentrations more often in aCCP-positive patients with RA (P = 0.06).
CONCLUSIONS: Patients with RA had worse periodontal conditions than HC participants. Although a trend for higher F. nucleatum and P. gingivalis concentrations in aCCP-positive patients with RA was found, importance of periodontal pathogenic bacteria and rheumatoid parameters in the interrelationship between periodontitis and RA remains unclear.

Entities:  

Keywords:  Arthritis, rheumatoid; Porphyromonas gingivalis; bacteremia; biofilms; citrulline; periodontitis

Mesh:

Year:  2016        PMID: 27858553     DOI: 10.1902/jop.2016.160355

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  20 in total

1.  Expression of human and Porphyromonas gingivalis glutaminyl cyclases in periodontitis and rheumatoid arthritis-A pilot study.

Authors:  Philip Bender; Andreas Egger; Martin Westermann; Nadine Taudte; Anton Sculean; Jan Potempa; Burkhard Möller; Mirko Buchholz; Sigrun Eick
Journal:  Arch Oral Biol       Date:  2018-10-28       Impact factor: 2.633

2.  Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the plasmatic and salivary levels of RANKL and Survivin: a short-term clinical study.

Authors:  Marcela Faria Moura; Tarcília Aparecida Silva; Luís Otávio Miranda Cota; Sicilia Rezende Oliveira; Fernando Queiroz Cunha; Gilda Aparecida Ferreira; José Roberto Cortelli; Sheila Cavalca Cortelli; Fernando Oliveira Costa
Journal:  Clin Oral Investig       Date:  2021-05-05       Impact factor: 3.573

Review 3.  The case for periodontitis in the pathogenesis of rheumatoid arthritis.

Authors:  Jan Potempa; Piotr Mydel; Joanna Koziel
Journal:  Nat Rev Rheumatol       Date:  2017-08-24       Impact factor: 20.543

4.  Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: a case-control cross-sectional study.

Authors:  Kazu Takeuchi-Hatanaka; Yoshinobu Koyama; Kentaro Okamoto; Kyosuke Sakaida; Tadashi Yamamoto; Shogo Takashiba
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

5.  The association between rheumatoid arthritis and periodontal disease in a population-based cross-sectional case-control study.

Authors:  Stefan Renvert; Johan Sanmartin Berglund; G Rutger Persson; Maria K Söderlin
Journal:  BMC Rheumatol       Date:  2020-07-20

6.  Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study.

Authors:  Dirk Ziebolz; David Douglas; Donya Douglas; Jan Schmickler; Daniel Patschan; Gerhard A Müller; Rainer Haak; Jana Schmidt; Gerhard Schmalz; Susann Patschan
Journal:  Rheumatol Int       Date:  2018-03-20       Impact factor: 2.631

7.  Association of liver enzyme levels and alveolar bone loss: A cross-sectional clinical study in Sado Island.

Authors:  Ayumi Kuroki; Noriko Sugita; Shigeki Komatsu; Akio Yokoseki; Akihiro Yoshihara; Tetsuo Kobayashi; Kazutoshi Nakamura; Takeshi Momotsu; Naoto Endo; Kenji Sato; Ichiei Narita; Hiromasa Yoshie
Journal:  J Clin Exp Dent       Date:  2018-02-01

8.  Analysis of Socioeconomic Status in the Patients with Rheumatoid Arthritis.

Authors:  Deng-Ho Yang; Jing-Yang Huang; Jeng-Yuan Chiou; James Cheng-Chung Wei
Journal:  Int J Environ Res Public Health       Date:  2018-06-07       Impact factor: 3.390

9.  Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease.

Authors:  Ildikó Tar; Éva Csősz; Edit Végh; Karin Lundberg; Nastya Kharlamova; Boglárka Soós; Zoltán Szekanecz; Ildikó Márton
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.

Authors:  Liang-Gie Huang; Gin Chen; Der-Yuan Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.